Design Therapeutics, Inc. (DSGN)
9.065
-0.06
(-0.60%)
USD |
NASDAQ |
Jan 13, 09:44
Design Therapeutics EPS Diluted (Quarterly): -0.2984 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bruker Corp. | -0.4111 |
| AVITA Medical, Inc. | -0.4644 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.00M |
| Total Expenses (Quarterly) | 17.00M |
| Enterprise Value | 315.28M |
| Earnings Yield | -13.09% |
| Normalized Earnings Yield | -13.09 |